Hereditary Angioedema (HAE)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Publisher Name :
Date: 01-Nov-2016
No. of pages: 100
This report is available at upto 40% Discount. To avail discount please contact at +1-888-391-5441 / sales@rnrmarketresearch.com.
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's Report, "Hereditary Angioedema (HAE)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Hereditary Angioedema (HAE) Report is to understand the market and pipeline status of the drugs around the Hereditary Angioedema (HAE) to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight's Report provides the historical and forecasted sales of the drugs till 2018. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Hereditary Angioedema (HAE). While the leading brands, companies and chemicals are considered thoroughly, DelveInsight's report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.

Scope:

- A snapshot of the global Market and Phase III therapeutics scenario for Hereditary Angioedema (HAE).

- A review of the marketed products under prescription for Hereditary Angioedema (HAE), regulatory information and marketing status.

- Coverage of global patent coverage and detailed commentaries on the US patent challenges.

- Graphical representation of investigational products for patent expiry and market exclusivities across the globe.

- Product profiles for marketed products for Hereditary Angioedema (HAE) with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.

- Coverage of API Manufacturers for Hereditary Angioedema (HAE) drugs in the United States, Europe and Asian Regions with location details.

- Coverage of Regulatory filings in the US, Europe, and Asia specifically India and China for Hereditary Angioedema (HAE) drugs.

- Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Hereditary Angioedema (HAE) drugs.

- Coverage of Hereditary Angioedema (HAE) Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.

- Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.

- Key discontinued Marketed products.

- Global Sales Figure to 2018.

Reasons to buy

- Evaluate the marketing status and exclusivity details of Hereditary Angioedema (HAE) key products to exploit opportunities for generic drug development opportunities.

- Identify and understand important and diverse types of therapeutics under Phase III development for Hereditary Angioedema (HAE).

- Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Hereditary Angioedema (HAE).

- API intelligence over marketed drugs for Hereditary Angioedema (HAE) and gaining primary intelligence over active ingredients manufacturers across the globe.

- API intelligence over leading Phase III Pipeline drugs.

- Develop and design strategies by identifying the API manufacturers for Phase III Pipeline products to enhance and expand business potential and scope.

- Understanding the scope of the Phase III Drugs with nil regulatory filings.

- Understanding the chemical route of synthesis of approved drugs for Hereditary Angioedema (HAE).

- Uncovering opportunities in the rapidly growing US market.

Hereditary Angioedema (HAE)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Table of Contents

1. Indication Overview
2. Market Drugs Landscape
2.1 Marketed Drugs
2.2 Marketed Details of Drugs by Application Type
2.3 Marketed Details of Drugs (NDA) by Marketing Status
2.4 Marketed Details of Drugs by Patent Expiration Timeline
3. Global API Manufacturers Assessment
3.1 API Manufacturers by United States Drug Master File (US DMF) Status
3.2 API Manufacturers by US DMF Status (Drug Specific)
3.3 API Manufacturers in Europe by Country
3.4 API Manufacturers in India by State
3.5 API Manufacturers in China by Province
3.6 Marketed Details of Approved Drugs by Geography
4. Phase III Drugs Landscape
4.1 Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs
4.2 API Manufacturers by US DMF Status (Drug Specific)
5. Drugs Market Data and Forecasted Sales Figure-2018
6. Marketed Drugs for Hereditary Angioedema (HAE)
6.1 Drug Name
6.1.1 Drug Description
6.1.2 Global Active Pharmaceutical Manufacturers for Drug
6.1.3 Approval Status of Drug
6.1.4 Patent and Exclusivity Details for Drug
6.1.5 Company Profile and Financials
7. Phase III Drugs for Hereditary Angioedema (HAE)
7.1 Drug Name
7.1.1 Drug Description
7.1.2 United States Drug Master File (DMF)
8. Discontinued Drugs for Hereditary Angioedema (HAE)
9. Appendix
10. Methodology
11. Consulting Services
12. Contact Us
13. Disclaimer

List of Tables

Hereditary Angioedema (HAE) Therapeutic Market, US, Marketed Drugs by Application Type, 2016
Hereditary Angioedema (HAE) Therapeutic Market, US, Marketed Drugs by Marketing Status, 2016
Hereditary Angioedema (HAE) Therapeutic Market, US, (Year), 2016
Hereditary Angioedema (HAE) Marketed Drugs, API Manufacturers by US DMF Status, 2016
Hereditary Angioedema (HAE) Marketed Drugs, US DMF Status Drug Specific (Number), 2016
Hereditary Angioedema (HAE) Drugs, API Manufacturers, Europe by Country, 2016
Hereditary Angioedema (HAE) Drugs, API Manufacturers, India by State, 2016
Hereditary Angioedema (HAE) Drugs, API Manufacturers, China by Province, 2016
Hereditary Angioedema (HAE) Drugs, API Manufacturers by Geography 2016
Hereditary Angioedema (HAE) Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2016
Hereditary Angioedema (HAE) Therapeutic Market, Global Sales-2018 (in million USD)
API Manufacturers for Drug, 2016
Phase III Drugs for Hereditary Angioedema (HAE), 2016
Discontinued Drugs for Hereditary Angioedema (HAE), 2016

List of Figures

Hereditary Angioedema (HAE) Therapeutic Market, US, Marketed Drugs by Application Type (%), 2016
Hereditary Angioedema (HAE) Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2016
Hereditary Angioedema (HAE) Therapeutic Market, US, (Year), 2016
Hereditary Angioedema (HAE) Marketed Drugs, API Manufacturers by US DMF Status (%), 2016
Hereditary Angioedema (HAE) Marketed Drugs, US DMF Status Drug Specific (Number), 2016
Hereditary Angioedema (HAE) Drugs, API Manufacturers, Europe by Country, 2016
Hereditary Angioedema (HAE) Drugs, API Manufacturers, India by State, 2016
Hereditary Angioedema (HAE) Drugs, API Manufacturers, China by Province, 2016
Hereditary Angioedema (HAE) Drugs, API Manufacturers by Geography 2016
Hereditary Angioedema (HAE) Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2016
Hereditary Angioedema (HAE) Therapeutic Market, Global Sales 2018 (in million USD)
Drug, Patent/Exclusivity Expiry (Year), 2016
  • Europe Heparin Market Report 2016
    Published: 02-Dec-2016        Price: US 3900 Onwards        Pages: 121
    Notes: Sales, means the sales volume of Heparin Revenue, means the sales value of Heparin This report studies sales (consumption) of Heparin in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Hepalink - Changshan Biochemical - Qianhong Bio-pharma - Opocrin - Pfizer......
  • Global Thrombin (Human) Market Research Report 2016
    Published: 29-Nov-2016        Price: US 2900 Onwards        Pages: 109
    Notes: Production, means the output of Thrombin (Human) Revenue, means the sales value of Thrombin (Human) This report studies Thrombin (Human) in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering - Baxter - CSL - Bayer - Grifols - Octapharma - Shan......
  • Global Heparin Sales Market Report 2016
    Published: 25-Nov-2016        Price: US 4000 Onwards        Pages: 129
    Notes: Sales, means the sales volume of Heparin Revenue, means the sales value of Heparin This report studies sales (consumption) of Heparin in Global market, especially in USA, China, Europe, Japan, India and Southeast Asia, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Hepalink - Changshan Biochemical - Qianhong Bio-pharma - Opocrin - Pfi......
  • Global Heparin Sodium Market Research Report 2016
    Published: 25-Nov-2016        Price: US 2900 Onwards        Pages: 109
    Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. With the accelerated pace of life and increasing aging population, global morbidity and mortality of cardiovascular and cerebrovascular disease are increased year by year. Heparin sodium is an efficient solution to those diseases. With increasing downstream demand, global heparin sodium production also increased from 133698 Kg in 2011 to 189515 Kg in 2015, with an average increase rate of 9.11%. ......
  • Osteonecrosis - Pipeline Review, H2 2016
    Published: 23-Nov-2016        Price: US 2000 Onwards        Pages: 40
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Osteonecrosis - Pipeline Review, H2 2016, provides an overview of the Osteonecrosis (Musculoskeletal Disorders) pipeline landscape.Osteonecrosis is bone death caused by poor blood supply to the area. It is most common in the hip and shoulder, but can affect other large joints such as knee, elbow, wrist and ankle. Osteonecrosis can be caused by disease, or a severe trauma, such as a break or dislocation, that a......
  • Thrombocytopenia - Pipeline Review, H2 2016
    Published: 16-Nov-2016        Price: US 2000 Onwards        Pages: 163
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Thrombocytopenia - Pipeline Review, H2 2016, provides an overview of the Thrombocytopenia (Hematological Disorders) pipeline landscape.Thrombocytopenia is characterized by an abnormally low amount of platelets Low platelet levels occur due to less production of platelets in the bone marrow, increased breakdown of platelets in the bloodstream or in the spleen or liver. Symptoms include bleeding in the mouth and......
  • Global Heparin Sodium Market by Manufacturers, Regions, Type and Application, Forecast to 2021
    Published: 08-Nov-2016        Price: US 3480 Onwards        Pages: 116
    Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Scope of the Report: This report focuses on the Heparin Sodium in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, re......
  • Global Heparin Market by Manufacturers, Regions, Type and Application, Forecast to 2021
    Published: 07-Nov-2016        Price: US 3480 Onwards        Pages: 114
    Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machineScope of the Report:This report focuses on the Heparin in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and ......
  • Vasculitis-Pipeline Insights, 2016
    Published: 01-Nov-2016        Price: US 1250 Onwards        Pages: 60
    DelveInsight's, " Vasculitis-Pipeline Insights, 2016", report provides in depth insights on the pipeline drugs and their development activities around the Vasculitis. The DelveInsight'sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, funding......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs